- 13 Jan 2021
- By CME Group
- Topics: OTC Products
Seeking your feedback to validate paths forward and efficiently achieve adoption of risk-free rates (RFRs).
As the industry advances RFR markets, CME Group continues our collaborative approach to identify, understand, and create innovative solutions for hurdles faced by market participants.
Subject to regulatory approval, the CME Rulebook will incorporate ISDA IBOR Fallbacks in cleared OTC IRS for certain currencies, in coordination with the broader industry, on January 25, 2021.
Market participants have requested CCPs to consider converting existing IBOR swap exposures into new OIS contracts that follow RFR standards, with a cash adjustment to compensate for any changes in valuation.
This discussion document is intended to facilitate a more detailed conversation with our customers and corresponding industry groups on this topic. Please follow the below link to read more.
If you have any questions or wish to offer feedback on the document, please contact a member of the cleared swaps team.
About CME Group
As the world’s leading derivatives marketplace, CME Group is where the world comes to manage risk. Comprised of four exchanges - CME, CBOT, NYMEX and COMEX - we offer the widest range of global benchmark products across all major asset classes, helping businesses everywhere mitigate the myriad of risks they face in today's uncertain global economy.
Follow us for global economic and financial news.
© 2024 CME Group Inc. All rights reserved.